FTC
“Pharma Bro” Martin Shkreli charged by FTC for price fixing Daraprim
January 28, 2020Manufacturing and Production FTC, Martin Shkreli, New York Attorney General, Pharma Bro
Martin Shkreli, also known as the “Pharma Bro”, has been charged by the Federal Trade Commission for price fixing. The …
Bristol-Myers Squibb to sell off Celgene’s Otezla ahead of $74 billion merger
June 24, 2019Manufacturing and Production Bristol-Myers Squibb, Celgene, FTC, otezla, pharma, psoriasis
Bristol-Myers Squibb has agreed to sell off Celgene’s psoriasis treatment Otezla, to appease antitrust regulators. BMS will divest one of …
Teva settles ‘pay-to-delay’ case with FTC
February 21, 2019Business Services, Sales and Marketing FTC, Teva, antitrust, drugs, generics, monopoly
Teva Pharmaceuticals has settled a dispute with the Federal Trade Commission (FTC) over three separate federal court antitrust lawsuits involving …
Trump signs trust-busting biosimilar bill into law
October 11, 2018Business Services, Sales and Marketing FTC, Trump, biosimilars, generics, us politics
President Donald J Trump has signed off a law which requires drugmakers and pharma firms to reveal the details of …
AbbVie ordered to pay $448m over generic delays
July 2, 2018Sales and Marketing AbbVie, FTC, androgel, besins, branded generics, pharma
A US Judge has ordered pharmaceutical company AbbVie to pay $448 million after determining that the company had used sham …
FTC launches tool to help mobile health app developers determine applicable regulations
April 8, 2016Medical Communications, Sales and Marketing FDA, FTC, apps, health, health apps, regulation
The US Federal Trade Commission has created a new web-based tool for developers of health-related mobile apps to help them …
FTC files complaint against Endo for blocking generics of its pain drugs
April 1, 2016Business Services, Manufacturing and Production, Medical Communications, Sales and Marketing Endo International, FTC, legal, regulation
The US Federal Trade Commission (FTC) has filed a complaint against Endo International (Nasdaq: ENDP) alleging the company used illegal …
Teva settles generic ‘pay-to-delay’ case for $1.2 billion
May 29, 2015Sales and Marketing Cephalon, FTC, Teva, modafinil, provigil
Teva Pharmaceuticals has agreed to a $1.2 billion settlement for paying generic drug makers to delay challenging the patent for …
Federal Trade Commission sues AbbVie and Teva
September 9, 2014Manufacturing and Production, Sales and Marketing AbbVie, FTC, Teva, androgel, federal trade commission
Authorities in the US claim that AbbVie and Teva filed ‘sham’ lawsuits in a complicated pay-to-delay case for generic forms …
Pay-for-delay deals up 60% in US
May 6, 2011Sales and Marketing FTC, generics
Deals to delay generic drugs from coming onto the US market have more than doubled. The Federal Trade Commission’s staff …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
